Psilocybin mushrooms, commonly known as magic mushrooms, are a polyphyletic informal group of fungi that contain psilocybin which turns into psilocin upon ingestion.

Read more in the app

Transforming Lives: Psilocybin’s Remarkable Effect on Cancer-Related Depression

Exploring the Impact of Psilocybin on the Immune System: Insights from a Controlled Study on Healthy Participants

Psilocybin-Assisted Therapy for Depression: A review and meta-Analysis finds psilocybin to have a significantly greater antidepressant effect compared to the placebo drug used. Response and remission rates also favoured participants who received psilocybin.

MDMA, Psilocybin, And Ketamine: 3 Psychedelics With Different Mental Health ‘Use Cases’

Religious leaders given psilocybin say they "felt God"

A study found that "three weeks after dosing, psilocybin 25 mg and, to a lesser degree, 10 mg improved measures of patient-reported depression severity, anxiety, affect, and functioning."

MDMA, Psilocybin Authorized as Medicines in Australia

Australia Legalizes Psilocybin And MDMA Prescriptions As U.S. Patients Seek Similar Authorization

MDMA and Psilocybin Are Approved as Medicines for the First Time

Restrictions on Psilocybin 'Magic Mushrooms' Are Easing as Research Ramps Up

Self-administration of Psilocybin in the Setting of Treatment-Resistant Depression (TRD): Microdosing with the Fadiman Protocol (12 min read) | Innovations in Clinical Neuroscience [Jul 2022]

Promising results from psilocybin trial for treatment-resistant depression

Magic mushrooms’ psilocybin can alleviate severe depression when used with therapy

Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

Psilocybin Therapy Sharply Reduces Excessive Drinking, Small Study Shows

Psilocybin therapy seems to help some people give up drinking alcohol

More than 100 health-care professionals challenge rejection of psilocybin access

Two Cancer Patients Battle to Make Psilocybin Accessible for Palliative Care

Cannabis users expect cannabis-assisted therapy for depression to work as well as psilocybin-assisted therapy

Large survey suggests psilocybin is a “relatively safe” drug, with serious reactions being rare and short-lived